OUTCOMES OF CORNEAL ALLERGENIC INTRASTROMAL RING SEGMENT (CAIRS) SURGERY
Dr David Gunn, Ophthalmologist
Cornea, Cataract and Refractive Surgeon, Queensland Eye Institute
& Focus Vision Clinic in Brisbane, Queensland
RESEARCHER PROFILE (Filmed in Brisbane, Queensland, Australian | June 2024)
Dr David Gunn is an ophthalmologist specialising in cornea, cataract, and refractive surgery at the Queensland Eye Institute and Focus Vision in Brisbane, Queensland. His journey into ophthalmology began during medical school, inspired by a mentor. He initially engaged in research on mouse glaucoma, exploring amacrine cells and their responses.
After completing his residency and gaining experience in eye casualty at the Royal Brisbane Hospital, David underwent four years of surgical training in the Queensland network. This was followed by a stint at the Bristol Eye Hospital in the UK, focusing on the cornea and anterior segment. Since returning to Queensland, he has concentrated on keratoconus research.
One of the pivotal moments in his career was the decision to specialise in cornea surgery, which included performing Australia’s first CAIRS procedure in May 2021. His current research examines outcomes for patients undergoing Corneal Allergenic Intrastromal Ring Segment (CAIRS) surgery.
Dr Gunn finds immense satisfaction in the immediate post-operative results he sees in patients, as visual acuity provides a tangible measure of success. He is passionate about introducing less invasive surgical techniques that lead to improvements in patients’ lives.
-
Vascular cognitive impairment and dementia
Jessica Lo (Jess) is a Research Associate at the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney, Australia. For over seven years, she has been instrumental in leading and coordinating research for the international Stroke and Cognition Consortium (STROKOG), collaborating with global experts to address key questions related to vascular cognitive impairment and dementia.
-
Mechanisms of resistance to menin inhibitor therapy and Acute Myeloid Leukaemia
Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.
-
CASE STUDY increasing survival, free of bronchopulmonary dysplasia (BPD) in extremely preterm infants
The aim of the PLUSS trial was to find out if installation of budesonide (a steroid) with surfactant to the lungs of extremely preterm babies helps to prevent lung disease, or Bronchopulmonary dysplasia (BPD).
